Noxopharm Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
3.30
30.30
58.90
Gross Income
3.30
30.30
58.90
SG&A Expense
699.70
3,198.00
10,441.70
EBIT
703.10
3,228.30
10,500.60
Non Operating Income/Expense
2.00
9.10
1.60
Pretax Income
704.70
3,169.90
19,231
Income Tax
-
124.00
910.50
Consolidated Net Income
704.70
3,045.90
18,320.50
Net Income
704.70
3,045.90
18,283.50
Net Income After Extraordinaries
704.70
3,045.90
18,283.50
Net Income Available to Common
704.70
3,045.90
18,283.50
EPS (Basic)
0.01
0.04
0.17
Basic Shares Outstanding
75,171.40
77,335.80
105,119.80
EPS (Diluted)
0.01
0.04
0.17
Diluted Shares Outstanding
75,171.40
77,335.80
105,119.80
EBITDA
699.70
3,198.00
10,441.70
Non-Operating Interest Income
0.40
67.50
62.80
About Noxopharm
View Profile
